Spero Therapeutics (SPRO) Earnings Date and Reports 2024

1 day ago · When is Spero Therapeutics' next earnings announcement? View the latest SPRO earnings date, analysts forecasts, earnings history, and conference call transcripts. ... (SPRO) …

CouponFollow Extension

48%
OFF

Spero Therapeutics Inc Earnings Dates, Reports, Calls

2 days from now

On SPRO's earnings call on Invalid Date, . Spero Therapeutics (NASDAQ: SPRO) reported Q2 2024 earnings per share (EPS) of -$0.33, up 43.48% year over year. Total SPRO earnings for …

wallstreetzen.com

$0.33
OFF

What Date Does Spero Therapeutics's (SPRO) Report Earnings

2 days from now

For their last quarter, Spero Therapeutics (SPRO) reported earnings of -$0.33 per share, beating the Zacks Consensus Estimate of $-0.35 per share. This reflects a positive earnings surprise …

zacks.com

6%
OFF

Spero Therapeutics Earnings Dates, Upcoming And Historical

2 days from now

SPRO last reported earnings on November 14, 2024 after the market close (AMC). The company held a conference call for investors at on . SPRO shares declined -5.6% the day following the …

marketchameleon.com

$10
OFF

Earnings Flash (SPRO) SPERO THERAPEUTICS Posts Q3 Revenue …

2 days from now

Nov 14, 2024 · Spero Therapeutics, Inc., Q2 2024 Earnings Call, Aug 05, 2024 Aug. 05: Earnings Flash (SPRO) SPERO THERAPEUTICS Posts Q2 Revenue $10.2M, vs. Street Est of $3.3M …

marketscreener.com

12%
OFF

Spero Therapeutics Revenue 2015-2024 - Stock Analysis

2 days from now

6 days ago · Spero Therapeutics had revenue of $13.47M in the quarter ending September 30, 2024, a decrease of -47.12%. This brings the company's revenue in the last twelve months to …

stockanalysis.com

FAQs about Spero Therapeutics (SPRO) Earnings Date and Reports 2024 Coupon?

Did Spero Therapeutics release financial results for the second quarter 2024?

This afternoon, Spero Therapeutics released financial results and provided a business update for the second quarter of 2024. The press releases available on the investor page of the Spero Therapeutics' website. ...

Does Spero spr720 work against marketed antibiotics?

Spero has conducted extensive in vitro and in vivo studies, which have shown no evidence of cross resistance against marketed antibiotics as well as a low propensity for selection of resistance. Further, we have demonstrated SPR720 to be potent against multiple NTM pathogens. ...

Will Keros Therapeutics' earnings decrease next year?

Quarterly revenue rose 4750.0% year-over-year to $0.39 million. With a trailing EPS of -$5.13, Keros Therapeutics' earnings are expected to decrease next year, from ($4.90) to ($5.25) per share. ...